Your browser doesn't support javascript.
loading
Pharmacological intervention of cholesterol sulfate-mediated T cell exclusion promotes antitumor immunity.
Tatsuguchi, Takaaki; Uruno, Takehito; Sugiura, Yuki; Oisaki, Kounosuke; Takaya, Daisuke; Sakata, Daiji; Izumi, Yoshihiro; Togo, Takaya; Hattori, Yuko; Kunimura, Kazufumi; Sakurai, Tetsuya; Honma, Teruki; Bamba, Takeshi; Nakamura, Masafumi; Kanai, Motomu; Suematsu, Makoto; Fukui, Yoshinori.
Affiliation
  • Tatsuguchi T; Division of Immunogenetics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-k
  • Uruno T; Division of Immunogenetics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. Electronic address: uruno@bioreg.kyushu-u.ac.jp.
  • Sugiura Y; Department of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Oisaki K; Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Bunkyo-ku, Tokyo, 113-0033, Japan.
  • Takaya D; Laboratory for Structure-Based Molecular Design, RIKEN Center for Biosystems Dynamics Research, Kanagawa, 230-0045, Japan.
  • Sakata D; Division of Immunogenetics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Izumi Y; Division of Metabolomics, Research Center for Transomics Medicine, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Togo T; Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Bunkyo-ku, Tokyo, 113-0033, Japan.
  • Hattori Y; Department of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Kunimura K; Division of Immunogenetics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Sakurai T; Division of Immunogenetics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Honma T; Laboratory for Structure-Based Molecular Design, RIKEN Center for Biosystems Dynamics Research, Kanagawa, 230-0045, Japan.
  • Bamba T; Division of Metabolomics, Research Center for Transomics Medicine, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Nakamura M; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Kanai M; Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Bunkyo-ku, Tokyo, 113-0033, Japan.
  • Suematsu M; Department of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Fukui Y; Division of Immunogenetics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. Electronic address: fukui@bioreg.kyushu-u.ac.jp.
Biochem Biophys Res Commun ; 609: 183-188, 2022 06 18.
Article in En | MEDLINE | ID: mdl-35452959
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: CD8-Positive T-Lymphocytes / Neoplasms Type of study: Prognostic_studies Limits: Animals Language: En Journal: Biochem Biophys Res Commun Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: CD8-Positive T-Lymphocytes / Neoplasms Type of study: Prognostic_studies Limits: Animals Language: En Journal: Biochem Biophys Res Commun Year: 2022 Type: Article